Daly Richard J
5 of 14 shown
The 5 most recent of 14 visible filings, newest first.
- Aquestive Therapeutics, Inc. Director$95,095Open-market buy
- Aquestive Therapeutics, Inc. Director$4,236Open-market buy
- Aquestive Therapeutics, Inc. Director57,000 sharesGrant
- CATALYST PHARMACEUTICALS, INC. President and CEO115,283 sharesReturned to the issuer
- CATALYST PHARMACEUTICALS, INC. President and CEO40,013 sharesReturned to the issuer